Skip to main content
NIH funding notice RFA-AI-24-071

Promoting Innovative Research in Treponema pallidum Pathogenesis (R21 Clinical Trial Not Allowed)

Closed on November 4, 2024.

Posted
August 2, 2024
Close date
November 4, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,990,660 in first-year total cost, median $448,150.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 MN-M (M2)]7

Most frequent institutions

  1. UNIVERSITY OF WASHINGTON2
  2. BAYLOR COLLEGE OF MEDICINE1
  3. DALHOUSIE UNIVERSITY1
  4. RUTGERS BIOMEDICAL AND HEALTH SCIENCES1
  5. UNIVERSITY OF CONNECTICUT SCH OF MED/DNT1
Competing awards under RFA-AI-24-071 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Elucidating the Contribution of Genetic Recombination in Treponema pallidum to Syphilis Pathogenesis1R21AI193880-01LIEBERMAN, NICOLE ALANA PERRYUNIVERSITY OF WASHINGTON, WA$485,375ZAI1
2025Nutrient acquisition and cyclic nucleotide signaling in Treponema pallidum as underpinnings of stealth pathogenicity1R21AI194255-01CAIMANO, MELISSA JRADOLF, JUSTIN DUNIVERSITY OF CONNECTICUT SCH OF MED/DNT, CT$457,875ZAI1
2025Exploring T. pallidum Pathogenesis in the Placenta Using Novel In Vitro Models of Syphilis During Pregnancy1R21AI194017-01MYSOREKAR, INDIRA UBAYLOR COLLEGE OF MEDICINE, TX$451,956ZAI1
2025Exploring Factor H recruitment by Treponema pallidum to avoid complement-mediated killing1R21AI193789-01GIACANI, LORENZOUNIVERSITY OF WASHINGTON, WA$448,150ZAI1
2025Assessing pathogen persistence and the host response to Treponema pallidum in a newly developed mouse model of congenital syphilis1R21AI193788-01PARVEEN, NIKHATRUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ$445,250ZAI1
2025Systematic analysis of Treponema pallidum gene expression under host infection related conditions1R21AI193963-01DE LAY, NICHOLAS R.UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX$418,360ZAI1
2025Investigating Treponema pallidum pathobiology in the cervicovaginal niche1R21AI194001-01LITHGOW, KAREN VDALHOUSIE UNIVERSITY, NS$283,694ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AI-24-071: Promoting Innovative Research in Treponema pallidum Pathogenesis (R21 Clinical Trial Not Allowed) | ScienceDex | ConductScience